Research Progress of Naturally Originated Potential Drugs on Reversing Drug Resistance in Malignant Tumors

被引:0
|
作者
Deng, Xiaolan [1 ]
Chen, X. L. [1 ]
Li, Fuling [1 ]
Chen, Donglin [1 ]
Wang, Siqin [1 ]
机构
[1] Haikou Peoples Hosp, Dept Pharm, Haikou 570208, Hainan, Peoples R China
关键词
Natural medicine; chemotherapy; malignant tumor; drug resistance; CANCER;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer chemotherapy is considered to be an effective strategy to delay the occurrence, development and recurrence of tumors. However, multi-drug resistance is the main cause of treatment failure and recurrence in tumor patients, and the primary limiting factor for tumor cure. It is clinically pointed out that drug combination chemotherapy can improve the success rate of chemotherapy, but about 50 % of tumor cells are still resistant to drugs, which leads to chemotherapy failure. The mechanism of drug resistance to traditional chemotherapy drugs, targeted therapy drugs and immunotherapy drugs is complex. Reversing chemotherapy drug resistance and mastering the mechanism of drug resistance are challenges in cancer research. To solve the problem of multi-drug resistance in tumors and improve the efficiency of chemotherapy better, this paper reviews the potential pharmacological mechanism and research progress of natural active ingredients (including alkaloids, flavonoids, sesquiterpenoids, diterpenoids, triterpenoids, coumarins, lignans and natural biarylpolyphenols, etc.) in reversing chemotherapy drug resistance based on available relevant literature.
引用
收藏
页码:40 / 47
页数:8
相关论文
共 50 条
  • [21] Inhibition of γ-secretase/Notch pathway as a potential therapy for reversing cancer drug resistance
    Feng, Mei
    Santhanam, Ramesh Kumar
    Xing, Huan
    Zhou, Mingsheng
    Jia, Hui
    BIOCHEMICAL PHARMACOLOGY, 2024, 220
  • [22] Research Progress of Traditional Chinese Medicine Monomers in Reversing Multidrug Resistance of Breast Cancer
    Wang, Shuya
    Yang, Shuangyu
    Yang, Xiaojia
    Deng, Dan
    Li, Jie
    Dong, Mingqing
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2023, 51 (03): : 575 - 594
  • [23] Research progress on the tsRNA classification, function, and application in gynecological malignant tumors
    Wen, Jing-tao
    Huang, Zheng-hao
    Li, Qian-hui
    Chen, Xi
    Qin, Hong-lei
    Zhao, Yang
    CELL DEATH DISCOVERY, 2021, 7 (01)
  • [24] Research progress on the tsRNA classification, function, and application in gynecological malignant tumors
    Jing-tao Wen
    Zheng-hao Huang
    Qian-hui Li
    Xi Chen
    Hong-lei Qin
    Yang Zhao
    Cell Death Discovery, 7
  • [25] Research progress of exosomes in drug resistance of breast cancer
    Liu, Lihui
    Jiang, Daqing
    Bai, Shi
    Zhang, Xinfeng
    Kang, Yue
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 11
  • [26] Acquired Drug Resistance: Recognizing the Potential of Repurposed Drugs
    Alffenaar, Jan-Willem C.
    Sintchenko, Vitali
    Marais, Ben J.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (11) : 2038 - 2039
  • [27] Research progress on gene mutations and drug resistance in leukemia
    Ma, Xiangyu
    Xu, Jiamin
    Wang, Yanan
    Fleishman, Joshua S.
    Bing, Hao
    Yu, Boran
    Li, Yanming
    Bo, Letao
    Zhang, Shaolong
    Chen, Zhe-Sheng
    Zhao, Libo
    DRUG RESISTANCE UPDATES, 2025, 79
  • [28] Research Progress on the Drug Resistance of ALK Kinase Inhibitors
    Li, Zhen
    Liu, Fang
    Wu, Shuang
    Ding, Shi
    Chen, Ye
    Liu, Ju
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (14) : 2456 - 2475
  • [29] Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors
    Mu, Qingchun
    Lv, Yue
    Luo, Chunmei
    Liu, Xiaojing
    Huang, Chunming
    Xiu, Youcheng
    Tang, Longguang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [30] Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors
    Long, Wenqing
    Zhang, Lijun
    Wang, Yuxing
    Xie, Haijuan
    Wang, Lin
    Yu, Hongnu
    JOURNAL OF ONCOLOGY, 2022, 2022